This inventor holds 1 USPTO granted patent. Top assignee: Hualan Genetic Engineering Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Guifang Zhou: Innovator in Monoclonal Antibody Development
Introduction
Guifang Zhou is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions for treating various diseases related to angiogenesis.
Latest Patents
Guifang Zhou holds a patent for a monoclonal antibody specifically binding to human plasmalemma vesicle-associated protein PV-1. This invention includes a detailed description of the antibody's complementarity-determining regions (CDRs) for both the light and heavy chain variable regions. The monoclonal antibody can be utilized in pharmaceutical compositions for treating choroidal neovascularization fundus diseases and other related conditions.
Career Highlights
Zhou is currently associated with Hualan Genetic Engineering Co., Ltd., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the biotechnology sector.
Collaborations
Guifang Zhou collaborates with talented individuals such as Xiaoqi Song and Zui Chen, contributing to a dynamic research environment.
Conclusion
Guifang Zhou's contributions to monoclonal antibody research exemplify the innovative spirit in biotechnology. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile